| Prev Close: | 39.72 |
|---|---|
| Open: | 39.92 |
| Bid: | 39.81 x 200 |
| Ask: | 40.01 x 1000 |
| 1y Target Est: | 38.03 |
| Beta: | 0.13 |
| Next Earnings Date: | 22-Jul-13 |
| Day's Range: | 39.67 - 40.03 |
|---|---|
| 52wk Range: | 30.64 - 42.87 |
| Volume: | 8,235,887 |
| Avg Vol (3m): | 9,267,140 |
| Market Cap: | 65.51B |
| P/E (ttm): | 45.31 |
| EPS (ttm): | 0.88 |
| Div & Yield: | 1.40 (3.50%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Biotech Bulls Can Ignore The Warning Signs At Their Perilat Seeking Alpha(Thu 8:14PM EDT)
- Gilead's HCV Drug Pipeline Outshines Weak Q1 Resultsat Investor's Business Daily(Thu 6:36PM EDT)
- Final Glance: Pharmaceuticals companiesAP(Thu 6:05PM EDT)
- Top Fund Buys Focus On Defensive Stocks, Housingat Investor's Business Daily(Thu 5:45PM EDT)
- Gilead’s Hepatitis C Treatment Clears Virus in Eight Weeksat Bloomberg(Thu 4:21PM EDT)
- Midday Glance: Pharmaceuticals companiesAP(Thu 1:26PM EDT)
- Gilead Stock Pops As HCV Drugs Shine In Trialsat Investor's Business Daily(Thu 11:42AM EDT)
- Gilead reports positive test results from hepatitis C treatment studiesat MarketWatch(Thu 10:56AM EDT)
- Bristol-Myers EVP Sells More Than 353K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Thu 9:31AM EDT)
- What Does A Big Market Correction Actually Look Like?at Seeking Alpha(Thu 7:05AM EDT)
- Sanofi earnings slashed in first quarterAP(Thu 2:53AM EDT)
- [video] No Huddle Offense: Profits In the Pipeline?at CNBC(Wed, May 1)
- CVS Stock Hits All-Time High As Sales Of Generics Popat Investor's Business Daily(Wed, May 1)
- BRISTOL MYERS SQUIBB CO FinancialsEDGAR Online Financials(Wed, May 1)
- UPDATE 2-CVS Caremark profit rises, helped by generics, flu seasonat Reuters(Wed, May 1)
Press Releases
- Bristol-Myers Squibb Reports First Quarter 2013 Financial ResultsBusiness Wire(Thu, Apr 25)
- Former Pro Football Coach Bill Cowher Tells Men “No Excuses” When It Comes to Getting Screened for MelanomaBusiness Wire(Tue, Apr 23)
- Former Pro Football Coach Bill Cowher Tells Men "No Excuses" When It Comes To Getting Screened For MelanomaPR Newswire(Tue, Apr 23)
Reports
- BMY: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(May 2)
- Thomson Reuters Stock Report - BRISTOL-MYERS SQUIBB COMPANY (BMY-N)Thomson Reuters Stock Report(May 2)
- ValuEngine Detailed Valuation Report for BMYValuEngine, Inc.(May 2)